AIMS: Non-invasive diagnosis of allograft dysfunction is a major objective in the management of heart transplant (HTX) recipients. Speckle tracking echocardiography (STE) permits comprehensive assessment of myocardial function. It is well established that deformation indices are reduced in HTXs when compared with control subjects. However, it is unclear if the reduction in strain is a chronic progressive phenomenon in HTX patients. Method and results Follow-up transthoracic echocardiography (TTE) was performed 3 years after initial TTE in 20 'healthy' HTX patients (13.2 years post-transplantation at time of follow-up) with normal ejection fraction and angiographically ruled out allograft vasculopathy. Grey-scale apical views were recorded and stored for automated offline speckle tracking (EchoPAC 7.0, GE) of the 16 segments of the left ventricle. Strain analysis was performed in 320 segments 34.3 ± 3.7 months after initial assessment. Automated tracking of myocardial deformation for determination of longitudinal systolic strain was not possible in 24 (7.5%) segments at baseline and in 32 (10.0%) segments at follow-up (P = ns). The left ventricular ejection fraction (LVEF) was 61.9 ± 8.1% at the initial examination vs. 62.8 ± 5.8% 3 years afterwards (P = ns). Global longitudinal peak systolic strain was -14.0 ± 4.0 vs. -14.4 ± 2.8%, respectively (P = ns). CONCLUSION: This is the first study describing follow-up deformation parameters in HTX patients undergoing STE. 'Healthy' HTX patients with normal coronary arteries and normal ejection fractions showed no deterioration of longitudinal strain values 3 years after the initial assessment. Apparently, deformation values remain stable over the years as long as the LVEF is preserved.
AIMS: Non-invasive diagnosis of allograft dysfunction is a major objective in the management of heart transplant (HTX) recipients. Speckle tracking echocardiography (STE) permits comprehensive assessment of myocardial function. It is well established that deformation indices are reduced in HTXs when compared with control subjects. However, it is unclear if the reduction in strain is a chronic progressive phenomenon in HTXpatients. Method and results Follow-up transthoracic echocardiography (TTE) was performed 3 years after initial TTE in 20 'healthy' HTXpatients (13.2 years post-transplantation at time of follow-up) with normal ejection fraction and angiographically ruled out allograft vasculopathy. Grey-scale apical views were recorded and stored for automated offline speckle tracking (EchoPAC 7.0, GE) of the 16 segments of the left ventricle. Strain analysis was performed in 320 segments 34.3 ± 3.7 months after initial assessment. Automated tracking of myocardial deformation for determination of longitudinal systolic strain was not possible in 24 (7.5%) segments at baseline and in 32 (10.0%) segments at follow-up (P = ns). The left ventricular ejection fraction (LVEF) was 61.9 ± 8.1% at the initial examination vs. 62.8 ± 5.8% 3 years afterwards (P = ns). Global longitudinal peak systolic strain was -14.0 ± 4.0 vs. -14.4 ± 2.8%, respectively (P = ns). CONCLUSION: This is the first study describing follow-up deformation parameters in HTXpatients undergoing STE. 'Healthy' HTXpatients with normal coronary arteries and normal ejection fractions showed no deterioration of longitudinal strain values 3 years after the initial assessment. Apparently, deformation values remain stable over the years as long as the LVEF is preserved.
Authors: Justin Godown; Debra A Dodd; Michael Stanley; Corey Havens; Meng Xu; James C Slaughter; David W Bearl; Jonathan H Soslow Journal: Pediatr Transplant Date: 2018-03-25
Authors: Elvin Zengin; Dirk Westermann; Ulf Radunski; Francisco Ojeda; Kai Muellerleile; Hermann Reichenspurner; Stefan Blankenberg; Christoph Sinning Journal: Int J Cardiovasc Imaging Date: 2015-02-20 Impact factor: 2.357
Authors: Justin Godown; William A McEachern; Debra A Dodd; Michael Stanley; Corey Havens; Meng Xu; James C Slaughter; David W Bearl; Jonathan H Soslow Journal: Cardiol Young Date: 2019-06-17 Impact factor: 1.093
Authors: Andrew S Tseng; Umama S Gorsi; Sergio Barros-Gomes; Fletcher A Miller; Patricia A Pellikka; Alfredo L Clavell; Hector R Villarraga Journal: BMC Cardiovasc Disord Date: 2018-12-22 Impact factor: 2.298
Authors: Jihye You; Jeong Jin Yu; Mi Jin Kim; Seulgi Cha; Jae Suk Baek; Eun Seok Choi; Bo Sang Kwon; Chun Soo Park; Tae-Jin Yun; Young-Hwue Kim Journal: Pediatr Cardiol Date: 2021-01-19 Impact factor: 1.655